Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT). III. Generation of suppressor T cells by a suppressive extract derived from GT-primed lymphoid cells by unknown
IMMUNOSUPPRESSIVE FACTOR(S) SPECIFIC FOR 
L-GLUTAMIC ACIDS°-L-TYROSINE  5° (GT) 
III.  Generation of Suppressor T  Cells by a  Suppressive 
Extract Derived from GT-Primed Lymphoid Cells* 
BY CARL WALTENBAUGH,~  JACQUES THI~ZE,§ JUDITH A.  KAPP,I[ AND BARUJ 
BENACERRAF 
(From the Department of Pathology,  Harvard Medical  School,  Boston, Massachusetts  02115) 
Studies from our laboratory have demonstrated that the terpolymer of L- 
glutamic acid~°-L-alanine3°-L-tyrosine  1° (GAT)  1 stimulates the development of T 
cells  capable  of specifically suppressing  the  in  vivo  and  in  vitro  antibody 
responses of nonresponder mice (I-]-2  TM  haplotypes) to GAT complexed with the 
immunogenic carrier, methylated bovine serum albumin (MBSA) (1, 2). These 
studies were extended to another synthetic antigen, the copolymer  of L-glutamic 
acidS°-L-tyrosine  5°  (GT)  (3). GT  is  not immunogenic in  any of the  20  inbred 
mouse strains tested.  Preimmunization with GT has  a  suppressive effect on 
antibody responses to GT-MBSA in mouse strains bearing 1"1-2  ~,f,k." haplotypes, 
but not in strains with H-2 TM haplotypes. Spleen cells from GT-primed nonre- 
sponder BALB/c mice (1-1-2 d) specifically inhibit the GT-specific plaque-forming 
cell (PFC) responses to GT-MBSA of normal syngeneic mice (3). These suppres- 
sor cells are T cells as demonstrated by their sensitivity to anti-Thy-1 and C (C. 
Waltenbaugh,  unpublished observations).  Furthermore, GT-specific  suppres- 
sion was shown to be controlled by two complementing, H-2-1inked, immune 
suppressor genes (4, 5). 
Tada and associates have described a  cell-free antigen-specific T-cell factor 
extracted by sonication from spleen and thymus cells of immunized mice (6, 7). 
Kapp et al. (8) have demonstrated the preparation of a similar T-cell suppressive 
factor extracted from lymphoid cells of GAT-primed nonresponder mice. More 
recently, we have described the preparation of an active GT-specific suppressive 
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material extracted from spleen  and/or thymus cells of BALB/c  (H-2 d)  and 
B10.BR (H-2  k) strains (9). The GT-suppressive extracts are very similar to GAT- 
suppressive  factor,  moreover,  their  activity in  allogeneic strains  has  been 
investigated (9). Thus, BALB/c GT-suppressive extract was shown to suppress 
GT-MBSA responses in the  GT-nonsuppressor A/J  (H-2 a)  strain,  which can 
neither be suppressed by GT preimmunization nor produce a  GT-suppressive 
factor (GT-T~F) (9). In addition, we have shown that pretreatment of BALB/c 
mice with cyclophosphamide abolishes their ability to develop GT-specific  sup- 
pression; under these conditions injection of GT did not inhibit GT-MBSA  re- 
sponses  (10). However, administration of BALB/c  GT-suppressive extract to 
cyclophosphamide-treated BALB/c mice suppressed their GT-MBSA responses 
(10). These are two examples of suppression by the appropriate specific suppres- 
sive extract in mice unable to be specifically suppressed by antigen.  Collec- 
tively, these results indicate that specific suppressor factor can stimulate the 
development of suppressor T cells and suggest a two-step model for the induc- 
tion of antigen-specific suppression (9, 11). The first step is initiated by antigen, 
while the second is factor-mediated. According to this hypothesis: (a) cyclophos- 
phamide treatment of suppressor haplotype mice abolishes the first without af- 
fecting the second step; (b) A/J mice have a genetic defect at the antigen-initi- 
ated step, illustrated by their inability to produce suppressive factor. Like the 
cyclophosphamide-treated  animals, however, A/J mice can be suppressed by the 
appropriate suppressive extract. 
We have investigated further the stimulation of specific suppressor T cells by 
GT- and GAT-suppressor extracts. In this paper, we shall report (a) the suppres- 
sion of  the GT-MBSA response of BALB/c and GAT-MBSA response DBA/1 mice 
by the appropriate extracts administered up to 5 wk before antigenic challenge; 
(b) the considerably greater suppressive activity of the BALB/c GT-suppressive 
extract when injected 1 wk before immunization with GT-MBSA  compared to 
administration of extract on the day of immunization; (c) the in vivo adoptive 
transfer of GT-specific  suppression to normal, syngeneic recipient mice with 
spleen cells from suppressor or antigen-nonsuppressor mice injected, with GT- 
suppressive extract; (d) the in vitro suppression of GAT-MBSA responses of 
DBA/1 spleen cells by syngeneic spleen cells from mice primed with GAT-factor 
(GAT-TsF). These findings have led to the conclusion that both GT- and GAT- 
suppressive extracts stimulate the production of antigen-specific suppressor T 
cells and lend supportive evidence for the two-step model of suppression. 
Materials and Methods 
Mice.  BALB/c mice were purchased from Health Research Laboratories, Inc., West Seneca, N. 
Y. A/J and DBA/1 mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. Mice 
used in these experiments were 2-4 mo old and were maintained on laboratory chow and acidified, 
chlorinated drinking water ad lib. 
Antigens.  A preparation of GT with molar amino acid ratio Glu~°Tyff  ° and average tool wt of 
133,000  was  used  for  immunizations.  A  preparation  of  GAT  with  molar  amino  acid  ratio 
GlueOAla~CTyr  1° and average tool wt of 38,000 was used both for immunizations and sensitizing 
sheep erythrocytes (SRBC).  Both polymers were purchased from Miles Laboratories, Inc.,  Miles 
Research Products,  Elkhardt, Ind.  MBSA was purchased from Worthington Biochemical Corp., 
Freehold,  N.  J.  GT and GAT solutions and GT-MBSA complexes were prepared as previously 
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Preparation  of Cell-Free lmmunosuppressive  Extracts.  Cell-free extracts were prepared as 
described previously (8, 9). Briefly, BALB/c or DBA/1 mice were injected i.p. with 100 pg of GT in 
a mixture of aluminum-magnesium hydroxide gel (Maalox, W. H. Rorer, Inc., Fort Washington, 
Pa.) or with 10/~g GAT in Maalox, respectively, or with Maalox alone (control). 3 days later, the 
mice were sacrificed and spleens and thymuses removed. The tissues were teased, pooled, washed 
twice in Hanks' balanced salt solution, and resuspended to a final concentration of  6 x  l0  s cells/ml 
in a medium consisting of Eagles' minimum essential medium supplemented with 4 mM HEPES 
buffer, 2 mM L-glutamine, and 50 U each of penicillin and streptomycin (Microbiological Associ- 
ates, Bethesda, Md.). Cells were disrupted by a Sonifier Cell Disruptor, model W-140-E  equipped 
with a standard microtip (Heat Systems-Ultrasonics,  Inc., Plainview, N. Y.) by applying 50 W for 
5 rain to 3-8-ml samples. The sonicate was centrifuged for 1 h at 40,000 g. The resulting supernate 
was collected and stored at -80°C until use. The extracts were assayed either in vivo or in vitro at 
concentrations indicated in the tables or figure. 
Determination of Antigen Present in the Extracts.  GT was labeled with [14C] methylamine as 
follows: (a) GT (1 mg/ml final) was dissolved in a N/5 NaOH solution and was adjusted to pH 7.5 
with  HC1,  (b)  1-ethyl-3  (3-dimethylamino propyl)  carbodiimide (ECDI)  (30  mg/ml final)  was 
dissolved in water and adjusted to pH 7.5 with NaOH, (c) the ethanol of a solution containing 250 
~Ci of [~4C] methylamine (New England Nuclear, Boston, Mass.) was evaporated, (d) 1 mg of GT 
and  3  mg of ECDI  were  mixed with  the  radioactive  material  and  the  mixture  was  reacted 
overnight at room temperature. The mixture was then dialyzed three times against 500  ml of 
phosphate-buffered  saline (PBS). GT was labeled such that 1 pg of  antigen corresponded  to 6 x  103 
cpm. 
Mice were injected with 10 and 100/~g of [14C]labeled  GT in Maalox and 3 days later extracts 
were prepared as described in the previous section. The extracts were treated with Protosol (New 
England Nuclear) and bleached with H202. Quenching was determined  by adding a known amount 
of radiolabeled GT to control extracts. Based on the radioreactivity of the thymus and spleen 
extracts, we calculated that I ml of extract prepared from 6 x  108 thymic and spleen cells contains 
0.035/~g of GT if the animals were injected with 100 ~g of GT,  and about 0.003  pg of GT if they 
were injected with 10 pg of GT. 
Preparation  and  use  of Immunoadsorbent  Columns.  Anti-H-2D d and anti-H-2l d sera  ::,ere 
prepared by Dr. Martin Dorf. Anti-D  d was produced in (B10  x  LP.RIII)Fj mice immunized with 
18R lymphoid cells; anti-/d was from (C3H x  LG/ckc)F, mice immunized with C3H.OH lymphoid 
cells. All sera were collected after six or more immunizations; mice were bled individually, and the 
high-titered sera were pooled. Before use, the sera were adsorbed for 1 h at 4°C with thymocytes 
(10  s cells/ml) from mice of the strain used to produce the antiserum. Anti-H-2D d and anti-H-21 d 
alloantisera were heat-inactivated (56°C for 30 min) before coupling the corresponding globulin 
fractions to CNBR-activated Sepharose 4B  (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) 
(12). The immunoadsorbents  were stored at 4°C in PBS-containing 0.02% sodium azide. Before use, 
2 ml anti-H-2/~-Sepharose or anti-H-2Id-Sepharose  were packed in 5-ml columns and extensively 
washed in PBS. 2-ml samples of  the crude extract diluted 1/lO (equivalent to 6 x  l0  T  lymphoid cells/ 
ml) were adsorbed on the gels for 3 h  at 4°C.  Various dilutions of the unbound material were 
immediately injected i.v. into BALB/c mice 7 days aRer injection with column eluates, the mice 
were immunized with GT-MBSA. 
Immunizations.  Mice were injected i.v. with 0.5  ml of the appropriate dilution of extract or 
antigen as indicated in the tables and figure. At the appropriate time interval, after antigen or 
extract administration, mice were immunized with 10 gg GT as GT-MBSA or 10 gg GAT as GAT- 
MBSA  in complete Freund's adjuvant (CFA) or in Maalox and 2 x 109 killed Bordetella pertussis 
organisms (Eli Lilly  and Company,  Indianapolis, Ind.).  In certain instances, mice were injected 
with 0.5 ml of 1% (vol/vol)  SRBC  suspension in saline. 
In Vivo and In Vitro  Cell  Transfer.  Mice used as spleen cell  donors were injected i.v. 7 days 
before transfer with 0.5 ml BALB/c Maalox- or GT extracts equivalent to 15 x 10  ~  lymphoid cells. 
Single cell  suspensions in Hank's balanced salt solution were prepared, washed,  and 20 x  10  ~ 
lymphoid cells  were adoptively transferred i.v.  into recipient mice. In certain experiments, Thy-1- 
bearing cells  were depleted from normal spleen cell  suspensions by treatment with appropriate 
concentrations of AKR  anti-Thy-1 C3H  and a 1:3 dilution of guinea pig serum as a source of C. 
Immediately after cell  transfer, the mice were immunized with 10/~g GT as GT-MBSA  in either 
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For  in  vitro  studies,  DBA/I mice  were  injected  i.v.  with  0.5  ml  of  an  extract  prepared  from  a pool 
of  thymus and spleen cells  from either  Maalox- or GAT-primed mice. 6 days later,  replicate  1-ml 
cultures  containing 8 x 10  6  normal DBA/1 spleen  cells  were  established  according  to  the  modifica- 
tions  of the Mishell-Dutton system used in our laboratory (1, 2), 2-8 x  10  6 spleen cells  from 
normal,  Maalox-  or  GAT-suppressive  extract-primed  DBA/1 mice  were added  at  culture  initiation. 
The IgG plaque-forming  cell  (PFC) responses were measured 5 days later. 
Hemolytic Plaque Assay.  7  days  after  injection  of  antigen or  5  days  aRer  culture  initiation,  IgG 
PFC responses  were  determined  by  using  GAT-SRBC as  indicator  cells  as  described  previously  (1). 
As  in  earlier  studies,  GT-MBSA  responses were assayed  on  SRBC coupled with  the  cross-reacting 
polymer  GAT, (GAT-SRBC) (3).  GT-  or  GAT-specific IgG  plaques were determined  by  subtracting 
the number of  PFC detected in the presence of  a suitable  dilution  of  GAT from the number of 
plaques  detected  on GAT-SRBC in  the absence  of  the  specific  inhibitor.  All  assays were  performed 
fn duplicate  and the number of  IgG PFC's per spleen recorded. 
Results 
Effect of Time  of Administration  of Suppressive Extracts  on  the PFC Re- 
sponses of  BALB /c and DBA/1 Mice.  In experiments reported previously (8, 9), 
suppressive extracts were administered on the day of GT-MBSA or GAT-MBSA 
immunization.  We investigated  whether  BALB/c GT-suppressive  extract  can 
inhibit  BALB/c  GT-MBSA  PFC  responses  when  administered  1 or  more  wk 
before GT-MBSA  challenge.  Injection  of BALB/c  GT-suppressive  extracts  at 
time  intervals  up  to  3  wk  before  antigenic  challenge  results  in  near  total 
suppression of the BALB/c GT-MBSA responses in vivo (Table I). Extracts from 
Maalox-primed control mice, on the other hand,  do not suppress the GT-MBSA 
response when injected the same day as antigen  or 7 days before antigen  (see 
Table IX).  Similarly,  extracts prepared from thymus and spleen cells of GAT- 
primed DBA/1 mice were administered  at various time intervals before GAT- 
MBSA immunization,  (Table-D. Likewise, administration of DBA/1 GAT-T6F up 
to 34 days before antigeni~Challenge  suppresses the GAT-MBSA PFC responses 
of DBA/1 mice. 
Increased Inhibitory Activity of BALB/c GT-Suppressive Extract when Ad- 
ministered I  wk before GT-MBSA.  The effectiveness of BALB/c GT-suppres- 
sive extract in inhibiting  GT-MBSA responses was compared when serial dilu- 
tions of the extract were administered on the day of or 1 wk before immunization 
with GT-MBSA (Table H). The BALB/c GT-suppressive extract was effective at 
an 8-10 times lower concentration when administered 1 wk before immunization 
with GT-MBSA than on the day of immunization. 
Free GT Cannot Explain the Suppressive Activity of the Extracts.  A serious 
concern  in  the  above experiments  is the  possibility that  small  quantities  of 
soluble antigen may be carried over in the suppressive extracts from the primed 
animals and the characteristics attributed to a suppressive factor may be due to 
trace amounts of antigenic contamination.  We have, therefore, investigated (a) 
the minimal amout of free antigen required to induce antigen-specific suppres- 
sion  when  administered  1  wk  before  GT-MBSA  immunization  and,  (b)  the 
amount of antigen present in the extract.  Fig. 1 shows the effects of injection of 
different  doses of GAT  or  GT  intravenously  into  DBA/1  and  BALB/c  mice, 
respectively, either on the day of immunization  or 1 wk before antigenic chal- 
lenge. BALB/c mice are suppressed by i.v. injection of 1.0/~g GT on the day of 
GT-MBSA immunization.  However, the i.v. administration  of 0.1 ftg GAT into 974  FACTOR  GENERATED  SUPPRESSOR  T  CELLS 
TASLE  I 
Effect of Time of Administration of BALB/c GT-T,F or DBA/1 GAT-T,F on the 
Respective GT-MBSA or GAT-MBSA PFC Responses of BALB/c or DBA/1 Mice 
Time inter- 
val* be- 
Extract*  tween ex-  BALB/c GT-spe-  Suppres-  DBA/1 GAT°spe-  Suppres- 
adminis-  tract injec-  cific IgG PFC re-  cific IgG PFC re- 
tered  tion and  sponses per spleen§  si°n~l  sponses per spleen§  sion 
immuniza- 
tion 
days  Arithmetic mean +- SE  %  Arithmetic mean +_ SE  % 
None  0  7,000 _+ 862  6,051  -+ 638 
Maalox  0  6,810  _+ 1,169  4,593  -+ 404¶ 
TsF  0  1,480 _+ 479  79  363  -- 55  94 
T,F  3-4  735  -+ 357  90  536  -+ 223  91 
TsF  7  1,266  _+ 556  82  334  _+ 76  94 
T~F  14  208 _+ 42  97  ND** 
T,F  21  1,462 _+ 79  79  ND 
T~F  34  ND  457  _+ 136  92 
* Extracts prepared from a pool of spleen and thymus cells from either Maalox- or GT-primed 
BALB/c mice or Maalox- or GAT-primed DBA/1 mice were injected i.v. into BALB/c or DBA/1 
mice, respectively; extracts equivalent to 15  x  10' cells were administered. 
* BALB/c mice were immunized i.p. with 10 ~g GT as GT-MBSA in CFA and DBA/1 mice were 
immunized i.p. with 10/~g GAT as GAT-MBSA in Maalox andB. pertussis as adjuvant. 7 days 
later, the number of antigen-specifc PFC per spleen was determined. 
§ Numbers represent the arithmetic mean of antigen-specific PFC per spleen  -+ SE for 6-15 
animals per data group. 
II Percent suppression is expressed for those groups that are statistically different from control 
response (no extract) group. In all cases, P  <  0.001 as determined by Student's t test. 
¶ This group is not statistically  different (P = 0.113) from the control GAT-MBSA response group. 
** Not determined. 
DBA/1  or  0.1  /~g  GT  into  BALB/c  1  wk  before  immunization  significantly 
suppresses  the  GAT-MBSA  or  GT-MBSA  responses,  respectively.  Therefore, 
GT-specific  suppression  can  be  easily  induced  with  10  times  less  antigen  or 
suppressive  extract  when  injected  1  wk  before  GT-MBSA  immunization.  Al- 
though it is unlikely that the extract contains suppressive doses of antigen,  it is 
very  important  to  eliminate  the  possibility that  the  suppressive  extract  is 
contaminated  with suppressive quantities of free copolymer. Therefore, we have 
radiolabeled  GT  with  [14C]methylamine  and  quantitated  the  amount  of  GT 
present  in  the  extracts  prepared  in  the  usual  manner  (see  Materials  and 
Methods). By this method, we have determined  that the amount  of radioactivity 
recovered ai~r  injection of 100/~g GT/mouse  corresponds to 0.035  tzg GT/ml of 
undiluted  extract.  Consequently,  0.5 ml of suppressive extract diluted 1/2 to 1/4 
(which induces near total suppression when injected on the day of immunization 
with GT-MBSA) contains 0.004-0.009/~g GT which is at least 100 times less than 
the  minimum  i.v.  dose of GT  which  gives detectable suppression  under  these 
conditions  (Fig.  1).  Similarly,  injection  of 0.5-ml  extracts  7  days  before  GT- 
MBSA yields near total suppression at dilutions of at least 1/84 (Table II) which 
is equivalent to 0.0003  ftg GT which is at least 100 times less than the minimum 
dose  of  antigen  required  for  significant  suppression  (Fig.  1).  We  may  then C.  WALTENBAUGH,  J.  TH~ZE,  J.  A.  KAPP,  AND  B.  BENACERRAF  975 
TABLE II 
Titration of  BALB  /c GT-Suppressive Extract Injected on the Day of or 7 
Days before GT-MBSA Immunization of BALB/c Mice 
Interval be- 
tween* injec- 
tion of extract  BALB/c  GT-specific IgG PFC 




Arithmetwmean ± SE 
None  9,291  ±  440  - 
1:2  <200  <0.001 
1:4  675  ±  284  <0.001 
1:8  2,884  ±  1,442  0.007 
1:16  9,218  ±  1,538  0.957 
7 days 
None  4,600  ±  605  - 
1:4  212  ±  12  0.004 
1:8  212  ±  12  0.004 
1:16  212  __.  12  0.004 
1:32  <200  0.003 
1:64  600 ±  400  0.001 
1:128  5,600  ±  1,987  0.582 
1:256  3,550  ±  1,354  0.446 
* BALB/c mice were immunized i.p.  with i0 ~g GT as GT-MBSA  in  complete 
Freund's  adjuvant  either  immediately  or  7  days  aider  injection  of  extracts. 
* GT-suppressive extract  was prepared from a pool  of  thymocytos and spleen 
cells  from  GT-primed  BALB/c mice. 1/s  ml  of  extract,  initially  equal  to  3 x 108 
cells,  was administered  i.v.  at  the appropriate dilution  as indicated 
§ 7 days  aRer GT-MBSA  immunization, antigen-specific  IgG  PFC were deter- 
mined.  Numbers represent  the  arithmetic  mean ± SE for  six  mice  per  control 
groups, those receiving  no factor,  and four mice per group, those receiving 
factor. 
conclude that the amount of  GT present in  the extracts  cannot account by itself 
for  their  suppressive activity. 
Adsorption of the GT-Suppressive Activity by Alloantisera Directed against 
the I  Subregion  of the H-2  Complex.  We have  determined  that  GT-Ts  F  ex- 
tracted from GT-primed BALB/c mice is an I region product;  ~ more precisely the 
GT-TsF extracted from B10.BR mice bears determinants  of the I-J  subregion 
(13).  These results were obtained in  vitro by the  addition of alloantisera  ad- 
sorbed extract at culture initiation.  It remained to be established whether the 
suppressive activity of the BALB/c GT-suppressive extract administered 7 days 
before antigenic challenge is also an H-2 product. Table III demonstrates that 
the suppressive activity is totally removed by alloantisera directed against H-2I  d 
when the extract is assayed at 1/so dilution and partially removed when assayed 
at 1/2o dilution.  When the suppressive extracts are incubated with an immuno- 
adsorbent made with alloantisera directed against H-2D ~, no loss of suppressive 
activity is seen at any dilution tested. 
2  Th~ze, J., C. Waltenbaugh, R. Germain, and B. Benacerraf. 1977.  Immunosuppressive fac- 
tor(s)  specific  for L-glutamic acidS°-L-tyrosine  5° (GT).  IV. In vitro  activity  and immunochemical 
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FIG.  1.  Effect of intravenous injection of GAT or GT on the respective GAT-MBSA or GT- 
MBSA PFC responses of DBA/1 or BALB/c mice. DBA/1 mice (upper panel) injected with 
the appropriate amounts of GAT were immunized  7 days later with GAT-MBSA; I wk later 
the numbers of GAT-specific PFC per spleen were determined. Statistical comparisons of 
control GAT-MBSA PFC responses (dotted bar) with those groups receiving preimmuniza- 
tion with GAT gave the following results; 10, 1, 0.1 ~tg GAT yieldedP < 0.002 in all cases, 
while 0.01 and 0.001 pg GAT yielded P> 0.470. 
BALB/c mice (lower panel) were injected intravenously  with the appropriate  amount of GT 
on the same day as GT-MBSA immunization  (©  ..... ©) or 7 days before GT-MBSA immuni- 
zation (A  ......  A). 1 wk after GT-MBSA immunization  the numbers of GT-specific PFC per 
spleen were determined. Statistical comparisons of control GT-MBSA PFC responses (dot- 
ted bar) with those groups receiving GT preimmunization  gave the following results: GT 
injected the same day as GT-MBSA; 100, 10,/~g GT yieldedP < 0.002 in all cases, while 0.1, 
0.01, 0.001 pg GT yielded P  > 0.530. GT injected 7 days before GT-MBSA 10, 1, 0.1 ~g GT 
yielded P  <  0.001, whereas, 0.01 and 0.001 ~g GT yielded P  > 0.2. 
Transfer of Suppression  with Spleen  Cells from Mice Treated with Suppres- 
sive Extract.  The hypothesis that BALB/c GT-suppressive extract inhibits GT- 
MBSA PFC responses by stimulating the production of GT-suppressor T  cells 
was tested by the adoptive transfer of spleen cells from BALB/c mice injected 1 
wk  earlier with  BALB/c  GT-suppressive extracts  into normal  BALB/c recipi- 
ents.  Table  IV  illustrates such  an  experiment,  demonstrating  that  20  ×  l0  s 
spleen cells from BALB/c mice injected with BALB/c GT-suppressive extract 1 
wk  earlier  suppress  the  PFC  responses of normal  BALB/c  recipients to  GT- C.  WALTENBAUGH,  J.  TH~ZE,  J.  A.  KAPP,  AND  B.  BENACERRAF  977 
TABLE  m 
Effect of  Administration of  Alloantisera-Adsorbed BALB/c GT-Suppressive Extract 7 Days 






treatment*  mice per 
group  No extract 
-  8  15,050  -* 1,711 
Untreated  4 
Anti-H-21T  4 
Anti-H-2I  d  4 
Experiment II 
GT-specific IgG PFC per splcen$ 
Final dilution of extract 
-  4  7,362  -* 1,372 
Untreated  4 
Anti H-21T  4 
Anti-H-2I  d  4 
1/20  1/40  1/80 
Arithmetic mean  +_ SE 
458  -* 208 
344_*94 
7,469  ±  1,287 
1,375  ~: 428 
937  ~- 308 
4,050  +  2,019 
1,031  ±  452 
344+_44 




2,000  ±  954 
1,906  ±  1,494 




* Extracts were prepared from a pool of spleen and thymus cells from GT-primed BALB/c mice. 2-ml samples of crude extract diluted 1/10 
(equivalent to 6 x  107 lymphoid cells) were adsorbed with Sepharose-bound alloantiasra directed against H-2D  d and H-21 Q. The unbound 
material was injected (0.5 ml) immediately i.v. into BALB/c mice at dilutions indicated above. 
Mice were immunized i.p. with 10/zg GT as GT-MBSA in B. pertuss/s and Maalox as adjuvant 7 days al~er administration of extracts i.v. 7 
days alter immunization, the number of antigen-specific PFC per spleen was determined. 
§ Not determined. 
TABLE  rV 
BALB /c GT-Suppressive Extract Stimulates the Development of 
Suppressor Cells in BALB/c Mice 
Group*  GT-specific IgG*  Suppression  P  value 
PFC per spleen 
Arithmetic mean ± SE  % 
I  5,881  ±  1,504 
II  <200  97  0.002 
III  7,137  ±  2,195 
IV  262  ±  62  96  0.007 
V  8,540  ±  1,800 
VI  838  ±  419  90  0.007 
* Groups I and II. Normal BALB/c mice received i.v. injection of BALB/ 
c  Maalox extract (group I) or BALB/c GT-suppressive extract (group 
II), equivalent to 15 x  10' lymphoid cells. 7 days later, these mice were 
immunized intraperiteneally with 10/zg GT as GT-MBSA in CFA, i.p. 
Groups III and IV. Normal BALB/c mice received 20 x  l(P spleen cells, 
i.v., from BALB/c mice injected 7 days earlier with BALB/c Maalox 
extract  (group  III)  or  BALB/c  GT-suppressive  extract  (group  IV), 
equivalent to  15  x  107  lymphoid cells.  Immediately al~r  adoptive 
transfer,  the recipient mice were immunized with  10  ~tg GT as GT- 
MBSA in CFA, i.p. 
Groups V  and Vl. Normal mice received 20  ×  10  e spleen cells, i.v., 
from  BALB/c  mice  injected  7  days  earlier  with  BALB/c 
GT-suppressive extract adsorbed on an anti-H-21  d immunoadsorbent 
(group V) or on an anti-H-2D d immunoadsorbent (group VI). Immedi- 
ately after adoptive transfer,  mice were injected with  10  /zg GT as 
GT-MBSA in CFA, i.p. 
$ 7 days after GT-MBSA immunization the number of antigen-specific 
PFC per spleen was determined.  Numbers represent the arithmetic 
mean ±  SE for eight mice per group. 978  FACTOR  GENERATED  SUPPRESSOR  T  CELLS 
MBSA. The degree of suppression achieved by the transfer of spleen cells from 
suppressive  extract-treated  mice  (group  IV)  is  as  efficient  as  the  inhibition 
caused by injecting  suppressive extract  1 wk before GT-MBSA immunization 
(group II). On the other hand, spleen cells from Maalox extract-treated animals 
(group III) had no suppressive effect compared to mice receiving Maalox extract 
1 wk before GT-MBSA injection (group I). Furthermore,  the factor responsible 
for the generation of suppressor cells bears determinants  of the I  subregion of 
the H-2  complex.  This  was  demonstrated  by the  inability of cells from  mice 
previously injected with extracts adsorbed with alloantisera directed against Ho 
2I  d to transfer suppression (group V). However, suppressive extract passed over 
an  anti-H-2D d immunoadsorbent  was  still  able  to  generate  suppressor  cells 
(group VI). Table V shows that the cells that transfer suppression from BALB/c 
GT-suppressive extract-primed donors are sensitive to treatment with anti-Thy- 
1 antiserum  and C, thus demonstrating that this suppression is mediated by T 
cells. 
In Vitro Suppression of GAT-MBSA Response by Suppressor Cells Induced 
In Vivo by Suppressive Extracts.  DBA/1 mice were treated with DBA/1 GAT- 
suppressive extract 6 days before their cells were studied in culture (Table VI). 
Spleen cells from normal  DBA/1 mice (A) and from DBA/1 mice that received 
control extracts (B) develop PFC responses to GAT-MBSA, whereas spleen cells 
from DBA/1 mice that  received GAT-extracts  (C) do not.  In addition,  2  ×  10  ~ 
spleen cells from suppressive extract-treated mice were added to 8 ×  106 normal 
DBA/1  spleen  cells  in  vitro.  The  addition  of spleen  cells  from  suppressive 
extract-treated mice caused a marked suppression of GAT-MBSA PFC responses 
(F) as compared to cultures receiving spleen cells from Maalox extract-treated 
mice (E) or control cultures (D). 
Stimulation  of Suppressor  Cells  in A/J Mice  by BALB/c  GT-Suppressive 
Extract.  The GT-MBSA responses of A/J mice were shown to be unaffected by 
the  previous  i.p.  (5)  or  i.v.  injection  of GT  (14).  Table  VII  shows  that  i.v. 
injection of 100 ~g GT has no inhibitory effect on the GT-MBSA PFC responses 
of A/J mice. On the other hand,  BALB/c GT-suppressive extract was shown to 
suppress the GT-MBSA responses of A/J mice although A/J mice do not produce 
a  GT-TsF (9). These results suggested that A/J mice were genetically defective 
in cells capable of producing a Ts  F but did possess cells that could respond to the 
appropriate  suppressive  extract.  In  a  preliminary  series  of experiments  (not 
shown) we determined that BALB/c GT-suppressive extract administered  1 wk 
before antigenic  challenge  suppresses  the  GT-MBSA responses  of A/J  mice. 
Table VIII presents evidence that suppression can be transferred to normal A/J 
mice with spleen cells from A/J mice treated  1 wk earlier  with  BALB/c GT- 
suppressive extract.  This experiment can also be considered evidence that the 
generation of effector suppressor cells is stimulated by BALB/c GT-TsF and not 
the result of antigen alone present in the extract, since GT administered i.v. is 
not suppressive in A/J mice (Table VII). 
Specificity of Suppression Induced by Suppressive Extracts.  We have dem- 
onstrated above that BALB/c GT-suppressive extracts generate cells capable of 
suppressing the  GT-MBSA PFC responses of both BALB/c and A/J mice.  We 
have investigated the specificity of the extract-induced  suppression.  Table IX C. WALTENBAUGH,  J. TH~ZE, J. A. KAPP, AND B. BENACERRAF  979 
TABLE V 
Effect  of  Depletion  of  Thy-l-Positive  Spleen  Cells  from  BALB/e Mice Primed with  GT- 
Suppressive  Extract on the GT-MBSA PFC Responses of Normal Syngeneic  Recipients 
Donor BALB/c mice* 
Extract administered 
Treatment of  20 x 106 
spleen cells  transferred 
GT-specific IgG*  Suppres-  P value 
PFC per spleen  sion 
Arithmetic  mean  +_ 
Day 4  Day 0  SE  % 
None  No transfer  3,720 ~  968 
BALB/c Maalox  -  4,866 _~ 2,081  0  0.652 
BALB/c GT  -  <200  95  0.007 
BALB/c GT  Anti-Thy 1+ C'  3,960 ~- 790  0  0.852 
BALB/c GT  C'  683 ~- 234  82  0.009 
* Normal BALB/c  mice were  injected i.v.  with  BALB/c  Maalox-  or  GT-suppressive extracts 
equivalent to 15 × 10  z lymphoid cells. 4 days later, 20 x  106 spleen cells treated with anti-Thy-1 
and C, C or untreated were transferred into normal syngeneic recipients i.v. Immediately after 
cell transfer, mice were immunized with 10 ~tg GT as GT-MBSA in CFA, i.p. 
* 7 days after GT-MBSA immunization, the number of GT-specific IgG PFC were determined. 
Numbers represent the arithmetic mean -!-- SE for six mice per data group. 
TABLE VI 
Induction of Suppressor  Cells in the Spleens  of DBA/1 Mice Injected  with 
Lymphoid Cell Extracts from GAT-Primed DBA/1 Mice 
Mice injected with: spleen  GAT-spe- 
cells* from  cific IgG 
Normal spleen  responses  Percent 
Group  cells  in vitro  control 
Maalox  GAT-extract  PFC/10  ~  response§ 
extract  viable 
cells* 
A  8 x  106  -  -  664 
B  -  8 × I0  ~  -  900  135 
C  -  -  8  ×  106  60  9 
D  i0 × 106  -  -  891 
E  8 x 10  ~  2 × 10  e  -  683  76 
F  8 × 106  -  2 × 106  118  17 
* Spleen cells  from normal DBA/I mice or  DBA/I mice that  received 0.5  ml extract 
from  6 x 10  s  Maalox-primed  or  GAT-primed  DBA/1 lymphoid  cells  6  days  earlier. 
* Day 5 GAT-specific PFC responses stimulated by GAT-MBSA. 
§ Percent  control  responses were  calculated  by  comparing  groups  B and  C with  group 
A and groups  E and F with group D. 
demonstrates that  injection of GT-suppressive extract 7  days before antigenic 
challenge suppresses the GT-MBSA responses of BALB/c mice without dimin- 
ishing SRBC responses. Maalox extract shows no suppressive activity for either 
GT-MBSA or SRBC. In addition, the BALB/c GT-suppressive extract does not 
inhibit the SRBC  response even in the presence of GT-MBSA, thus excluding 
that  this  extract  in the  presence  of  antigen  acts  by  causing the  release  of 980  FACTOR  GENERATED  SUPPRESSOR  T  CELLS 
TABLE  VII 
Effect of GT Administered Intravenously on the GT-MBSA PFC 
Responses of  A/J Mice 
GT*  GT-specific  IgG§ PFC per spleen  P value 
p~  Arithmetic  mean -+ SE 
None  8,720 _+ 1,270  - 
100  8,180 _  983  0.745 
10  10,680 _+846  0.235 
1  11,620 _+ 1,815  0.227 
0.1  7,108 _+1,749  0.477 
0.01  10, 625 _+ 633  0.257 
* A/J Mice were injected intravenously with the indicated amount of 
soluble GT  in  0.5  ml  Hank's  balanced  salt solution.  Immediately 
thereafter,  mice were  immunized with  10  ftg GT as GT-MBSA by 
using Maalox and B. pertussis as adjuvant, i.p. 
* 7 days after GT-MBSA injection, the number of antigen-specific PFC 
per spleen were determined. Numbers represent the arithmetic mean 
-+ SE for eight mice per group. 
TABLZ  VIII 
Effect of BALB/c GT/Suppressive Extract on the Stimulation of 
Suppressor Cells in A/J Mice 
A/J spleen  cells  transferred* 
GT-specific IgG  Sup-  pres- 
PFC$ per spleen  sion 
P  value 
Arithmetic  mean  ± 
(20 ×  106)  SE  % 
No transfer  5,512 _+ 685 
BALB/c Maalox extract  6,793 -+ 903  0  0.270 
BALB/c GT extract  375 _+ 138  93  <0.001 
* Normal A/J mice were injected i.v. with BALB/c Maalox extract or BALB/c 
GT°suppressive extract, equivalent to 15 × 10  ~  lymphoid cells. 7 days later 20 
× 106 spleen cells were adoptively transferred into normal A/J mice. Immedi- 
ately after adoptive transfer, the recipient mice were immunized with 10 ~g 
GT as GT-MBSA in Maalox and B. pertussis as adjuvant, i.p. 
7 days after GT-MBSA immunization, the number of antigen-specific PFC 
per spleen were determined. Numbers represent the arithmetic mean ± SE 
for 12 mice per group. 
nonspecific-suppressive mediators.  An enhancement  of the  SRBC  responses of 
those mice receiving both GT-MBSA and SRBC is observed and this response is 
further enhanced  by injection of the GT-suppressive extract. Table X  illustrates 
that even the adoptive transfer of spleen cells from normal BALB/c mice primed 
with BALB/c GT-TsF has no suppressive effect upon the SRBC PFC responses of 
recipient mice. Thus, evidence is provided that the suppressor cells generated by 
BALB/c GT-TsF are antigen  specific. 
Discussion 
We  have  previously described specific suppressor  factors prepared  from  the 
spleen  and  thymuses  of GAT-  and  GT-primed  nonresponder  mice  (8,  9).  A1- C.  WALTENBAUGH,  J.  TH~ZE,  J.  A.  KAPP,  AND  B.  BENACERRAF  981 
TABLE IX 
Specificity of Suppression Induced  by Extracts of Lymphoid Cells from GT-Primed 
BALB/c Mice 
BALB/c  GT-specific  IgG  Supples- 
extract*  Antigen*  Indicator cells  PFC per spleen  sion 
Anti-SRBC PFC per spleen 




Arithmetic mean  %  Arithmetic mean 
*- SE  ± SE 
GT-MBSA  GAT-SRBC  8,650 ±  2,685 
SRBC  SRBC  20,580 ±  5,388  9,060 *- 3,925 
GT-MBSA +  SRBC  SRBC  42,900 *- 8,475  45,120 ±  13,528 
GT-MBSA  GAT-SRBC  9,700 ±  2,788  0 
SRBC  SRBC  32,160 *- 4,442  10,080 ±  409 
GT-MBSA +  SRBC  SRBC  49,680 ±  5,207  48,360 ±  16,852 
GT-MBSA  GAT-SRBC  1,150 ± 460  87 
SRBC  SRBC  34,440 ± 5,648  23,160 ±  5,697 
OT-MBSA  + SRBC  SRBC  67,740 ±  10,530  136,440  ±  21,573 
* Extracts prepared from a pool of spleen and thymus cells from either Maalox-  or GT-primed BALB/c mice were injected i.v.; extract 
equivalent to 15 x  10  s cells (a 1/20 dilution) were administered. 
* 7 days after administration of extracts, mice were immunized i.p. with l0/zg GT as OT-MBSA in Maalox andB. pertuseis and with 10  B 
SRBC in 0.5 ml saline. 7 days later the number of antigen-specific PFC per spleen was determined. Numbers represent the arithmetic 
mean ± SE for five mice per data group. 
TABLE X 
Specificity of Suppressor Cells Induced by Extracts of Lymphoid Cells from GT-Primed 
BALB/c Mice 
GT-speciflc  IgO*  BALB/c  Antigen  Indicator cells  Suppression 
extract*  PFC per spleen 
Anti-SRBC PFC per  spleen* 
IgM  IS'{3 
Arithmetic mean  %  Arithmetic mean  ±  SE 
± SE 
None  GT-MBSA  GAT-SRBC  4,845 *-  1,698 
SRBC  SRBC  22,833 ±  3,349  30,500 ±  6,018 
Mealox  GT-MBSA  GAT-SRBC  4,880*- 935  0 
SRBC  SRBC  39,725 ±  5,881  41,775 *- 9,199 
GT-T,F  GT-MBSA  GAT-SRBC  400*_ 200  91 
SRBC  SRBC  28,700 ±  3,975  24,975 ±  4,123 
* Extracts prepared from a pool of spleen and thymus cells from either Manlox-  or GT-primed BALB/c mice were injected i.v.; 
extract equivalent to 15 x  l{P cells (a 1/20 dilution) was administered. 7 days after injection of extract, 20 × 10  ° spleen cells were 
adoptively transferred into normal BALB/e mice. Immediately after transfer, recipient mice were immunized i.p. with 10 ~g GT 
as GT-MBSA in Maalox pertussls or with 10  e SRBC in 0.5 ml saline. 7 days later the number of anti-SRBC PFC per spleen were 
determined. 
* Numbers represent arithmetic mean *- SE for five mice per data group. 
though much has been learned concerning the immunochemical properties  of 
suppressor factors,  little  is known of  their mode of action. In this  report,  we 
propose a mechanism of  action  of  specific  suppressive factors. 
We have shown that injection  of suppressive extracts even several weeks 
preceding antigenic  challenge results  in  complete specific  suppression.  This has 
been established for both GT- and GAT-suppressive extracts in BALB/c and 
DBA/1 mice, respectively.  Furthermore, the quantity of suppressive extract 
required for the induction of suppression 1 wk before antigenic challenge is 
approximately 10 times less  than the amount required when the extract is 
injected  the same day as antigen.  This suggested a cell-mediated  amplification 
mechanism. We have, indeed, demonstrated the adoptive transfer  of  suppres- 982  FACTOR  GENERATED  SUPPRESSOR  T  CELLS 
sion induced by both GAT-TsF and GT-TsF. DBA/1 GAT-suppressive extract was 
injected into DBA/1 mice and the presence of suppressor cells was demonstrated 
in vitro by the suppression of the GAT-MBSA PFC responses of normal DBA/1 
spleen cells. BALB/c GT-suppressive extracts were injected into normal BALB/c 
and  A/J  mice;  7  days  later  their  spleen  cells were transferred into  normal 
syngeneic recipients, and the suppressive effects upon the normal GT-MBSA 
PFC responses were demonstrated. In BALB/c mice we demonstrated that the 
factor-induced suppression is mediated by T cells, as the transfer of suppression 
was abolished by treatment of the cell population with anti-Thy-1 and C.  In 
addition, the factor-generated suppressor cells are specific, and do not inhibit 
the responses to an irrelevant antigen. SRBC. 
We have shown in previous reports (12, 13) that the active suppressive moiety 
of GAT-  and GT-suppressive  extracts  are products of the I  region and  more 
specifically of the I-J subregion of the H-2 complex (14), in the case of B10.BR 
GT suppressor factor. In addition, they display affinity for antigen. We excluded 
the possibility that the suppression induced by suppressive extracts was due to 
low doses of free antigen. Several lines of evidence have been presented to this 
effect: (a)  the amount of free antigen present in  the suppressive  extracts  is 
insufficient to stimulate suppressor cells. We estimated, with radiolabeled GT, 
that the amount of antigen present in the suppressive extracts is at least 100 
times less  than  the  minimum suppressive  dose.  (b)  BALB/c  GT-suppressive 
extract generates effector suppressor cells in A/J mice, while preimmunization 
of A/J mice with a wide dose range of GT has no suppressive effect. This result 
definitely excludes the possibility that the activity of BALB/c GT-suppressive 
extract is due to free antigen itself. Aider excluding the presence of suppressive 
quantities of free antigen in suppressive extract, we have established that the 
factor responsible for the generation of suppressor T cells bears determinants 
controlled  by  the I  region  of the  1-1-2 complex.  It  remains  to  be  resolved, 
however, whether the factor responsible for the generation of suppressor T cells 
bears the same I-1-2 subregion determinants as the GT-suppressive factor al- 
ready described (14). To approach this question, we are currently investigating 
the possibility that alloantisera directed againstI-J  k will remove the B10.BR GT 
factor responsble for the generation of suppressor cells. 
We have recently proposed a  two-step model for the induction of antigen- 
specific suppression  (9).  The  first  step  is  antigen-mediated,  resulting in  the 
production of antigen-specific TsF;  the second step being factor-mediated. We 
postulate two T-cell populations for this model; one population produces TsF in 
response to antigen and this factor acts upon a  second distinct subset of cells 
which  then  become the  effector suppressor  T  cells.  There  are  two  lines  of 
evidence in support of this hypothesis: (a) we have shown previously (10) that 
the GT-MBSA PFC responses ofcyclophosphamide-treated BALB/c mice are not 
suppressed by GT but are suppressed by BALB/c GT-suppressive extract.  We 
propose that cyclophosphamide acts  by the elimination of the TsF-producing 
cells, while the second cell subset remains unaffected and can be activated by 
the appropriate suppressor factor. (b) Similarly, according to our hypothesis, A/ 
J  mice are genetically defective in cells capable of producing GT-TsF.  Accord- 
ingly, A/J mice are not suppressed by GT and cannot produce Ts  F, but can be C.  WALTENBAUGH,  J.  THI~,,ZE, J.  A.  KAPP,  AND  B.  BENACERRAF  983 
suppressed  by  BALB/c  GT-T~F.  The  results  presented  in  this  paper  are  in 
agreement with this hypothesis and demonstrate that suppressive factors act by 
inducing effector suppressor T cells. This has been established both in BALB/c 
and  A/J  mice  for  BALB/c  GT-suppressive  extracts  and  in  DBA/1  for  GAT- 
suppressive extracts. 
Further  characterization  of these  two  suppressor  T-cell  populations  is  re- 
quired.  Their relative radiosensitivities and cyclophosphamide sensitivities as 
well  as  their  Ly phenotypes  remain  to  be  determined.  Since  we  know  that 
B10.BR GT-TsF bears I-J determinants  (13),  it may be possible to distinguish 
one or the other population by the presence of cell surface markers controlled by 
the I-J subregion. 
Previous studies from our laboratory (12) demonstrated that the DBA/1 GAT 
suppressor activity in the crude extract was specifically retained by an anti-GAT 
immunoadsorbent  indicating  that  the  GAT-TsF  in  the  extract  is  bound  to 
antigen  or  antigenic  fragments.  Since  this  is  precisely the  type of material 
which has been shown in the experiments to stimulate the production of sup- 
pressor T cells, the possibility must be considered whether the material which 
stimulates  the  production  of suppressor  T  cells  is  a  very  active  complex  of 
specific suppressor factor and antigen at a concentration of antigen which is not 
suppressive  by itself.  Experiments  are  in  progress  to  resolve this  important 
point, z 
Biologically,  a  two-step  mechanism  for  specific  immune  suppression  has 
certain  advantages.  Activation  of a  limited  number  of factor-producing  cells 
would result in the generation of a greater number of effector suppressor T cells. 
Although  it  remains  to  be  established  whether  the  suppressor  factor  is  a 
secretory  product,  its  secretion  would  allow  the  widespread  distribution  of 
suppression  throughout  the organism.  In  addition,  a  limited  number of cells 
p~oducing factors  over an extended period of time may be responsible for a 
powerful, long-lasting suppression. Thus, the mediation of specific  immune 
suppression by two distinct  populations of  suppressor T cells  will  allow for the 
amplification  and maintenance of  suppression aider  antigenic  challenge. 
Summary 
Injection of mice  with L-glutamic  acidS°-L-tyrosine  5° (GT)- or L-glutarnic 
acid6°-L-alanineS°-L-tyrosine  TM (GAT)-specific  suppressor T-cell  factor  (GT-T~F or 
GAT-TsF)  up to 5 wk before antigenic challenge suppresses GT-methylated 
bovine serum albumin (MBSA) and GAT-MBSA  plaque-forming cells  responses. 
T suppressor cells  are  responsible  for  the suppression induced by  the suppressive 
extract  as demonstrated by adoptive transfer  and sensitivity  to anti-Thy-1 and 
complement treatment. We conclude that suppressive extract  induces specific 
suppressor T cells.  The material responsible  for  generation of  suppressor T cells 
is a product of the I subregion of the H-2 complex. We have excluded that 
suppressive quantities  of  antigens are present in the extract. 
A/J mice, which can neither be suppressed by GT nor make GT-TsF can be 
suppressed by BALB/c GT-T~F. Spleen cells  from BALB/c GT TsF-primed A/J 
s  Germain,  R. N.,  J.  Thbze,  J.  A. Kapp,  and  B. Benacerraf.  Manuscript  in  preparation. 984  FACTOR  GENERATED  SUPPRESSOR  T  CELLS 
mice can  adoptively transfer suppression  to normal  syngeneic recipients.  A/J 
mice appear to  be genetically defective in  cells involved in  factor production. 
These results  are  discussed  in  the  light  of a  two-step model  for  induction  of 
antigen-specific suppressor cells. 
We thank Dr.  M.  E.  Dorf for alloantisera against the mouse H-2  complex, Linda Kapp, and 
William Kwoka for excellent technical assistance, and Sharon Smith for the skillful typing of this 
manuscript. 
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